Cargando…
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study
OBJECTIVE: The frontal assessment battery (FAB) is a quick and reliable method of screening to evaluate frontal lobe dysfunction in amyotrophic lateral sclerosis (ALS). However, previous studies were generally conducted on small samples representing different stages of disease and severity. We asses...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563243/ https://www.ncbi.nlm.nih.gov/pubmed/26338835 http://dx.doi.org/10.1136/bmjopen-2014-007069 |
_version_ | 1782389275963162624 |
---|---|
author | Barulli, Maria Rosaria Fontana, Andrea Panza, Francesco Copetti, Massimiliano Bruno, Stefania Tursi, Marianna Iurillo, Annalisa Tortelli, Rosanna Capozzo, Rosa Simone, Isabella Laura Logroscino, Giancarlo |
author_facet | Barulli, Maria Rosaria Fontana, Andrea Panza, Francesco Copetti, Massimiliano Bruno, Stefania Tursi, Marianna Iurillo, Annalisa Tortelli, Rosanna Capozzo, Rosa Simone, Isabella Laura Logroscino, Giancarlo |
author_sort | Barulli, Maria Rosaria |
collection | PubMed |
description | OBJECTIVE: The frontal assessment battery (FAB) is a quick and reliable method of screening to evaluate frontal lobe dysfunction in amyotrophic lateral sclerosis (ALS). However, previous studies were generally conducted on small samples representing different stages of disease and severity. We assessed the diagnostic accuracy of the FAB in detecting executive functions and its association with demographic and clinical features in ALS without dementia. DESIGN: Retrospective observational study. SETTING: A multidisciplinary tertiary centre for motor neuron disease. PARTICIPANTS: We enrolled 95 consecutive patients with ALS diagnosed with El Escorial criteria in the period between January 2006 and December 2010. MAIN OUTCOME MEASURES: We screened the patients with ALS using the FAB. An Executive Index (EI) was also calculated by averaging the Z scores of analytic executive tests evaluating information-processing speed (Symbol Digit Modalities Test—Oral version), selective attention (Stroop test) and semantic memory (Verbal Fluency Test). RESULTS: The FAB detected executive dysfunction in 13.7% of the patients with ALS. Moreover, using the EI standardised cut-off, 37.9% of the patients with ALS showed executive dysfunction. The receiver-operating characteristic curve showed that the optimal cut-off for the FAB in the whole sample was 16, with a sensitivity of 0.889 (95% CIs 0.545 to 1.000), a specificity of 0.593 (95% CI 0.450 to 0.907) and a moderate overall discriminatory power of 0.809. Different levels of respiratory function, duration of disease and depressive symptoms did not affect the FAB validity. CONCLUSIONS: In patients with ALS without dementia, a high prevalence of executive dysfunction was present. The FAB showed good validity as a screening instrument to detect executive dysfunction in these patients and may be used when a complete neuropsychological assessment is not possible. |
format | Online Article Text |
id | pubmed-4563243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-45632432015-09-14 Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study Barulli, Maria Rosaria Fontana, Andrea Panza, Francesco Copetti, Massimiliano Bruno, Stefania Tursi, Marianna Iurillo, Annalisa Tortelli, Rosanna Capozzo, Rosa Simone, Isabella Laura Logroscino, Giancarlo BMJ Open Neurology OBJECTIVE: The frontal assessment battery (FAB) is a quick and reliable method of screening to evaluate frontal lobe dysfunction in amyotrophic lateral sclerosis (ALS). However, previous studies were generally conducted on small samples representing different stages of disease and severity. We assessed the diagnostic accuracy of the FAB in detecting executive functions and its association with demographic and clinical features in ALS without dementia. DESIGN: Retrospective observational study. SETTING: A multidisciplinary tertiary centre for motor neuron disease. PARTICIPANTS: We enrolled 95 consecutive patients with ALS diagnosed with El Escorial criteria in the period between January 2006 and December 2010. MAIN OUTCOME MEASURES: We screened the patients with ALS using the FAB. An Executive Index (EI) was also calculated by averaging the Z scores of analytic executive tests evaluating information-processing speed (Symbol Digit Modalities Test—Oral version), selective attention (Stroop test) and semantic memory (Verbal Fluency Test). RESULTS: The FAB detected executive dysfunction in 13.7% of the patients with ALS. Moreover, using the EI standardised cut-off, 37.9% of the patients with ALS showed executive dysfunction. The receiver-operating characteristic curve showed that the optimal cut-off for the FAB in the whole sample was 16, with a sensitivity of 0.889 (95% CIs 0.545 to 1.000), a specificity of 0.593 (95% CI 0.450 to 0.907) and a moderate overall discriminatory power of 0.809. Different levels of respiratory function, duration of disease and depressive symptoms did not affect the FAB validity. CONCLUSIONS: In patients with ALS without dementia, a high prevalence of executive dysfunction was present. The FAB showed good validity as a screening instrument to detect executive dysfunction in these patients and may be used when a complete neuropsychological assessment is not possible. BMJ Publishing Group 2015-09-03 /pmc/articles/PMC4563243/ /pubmed/26338835 http://dx.doi.org/10.1136/bmjopen-2014-007069 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Neurology Barulli, Maria Rosaria Fontana, Andrea Panza, Francesco Copetti, Massimiliano Bruno, Stefania Tursi, Marianna Iurillo, Annalisa Tortelli, Rosanna Capozzo, Rosa Simone, Isabella Laura Logroscino, Giancarlo Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study |
title | Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study |
title_full | Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study |
title_fullStr | Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study |
title_full_unstemmed | Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study |
title_short | Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study |
title_sort | frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563243/ https://www.ncbi.nlm.nih.gov/pubmed/26338835 http://dx.doi.org/10.1136/bmjopen-2014-007069 |
work_keys_str_mv | AT barullimariarosaria frontalassessmentbatteryfordetectingexecutivedysfunctioninamyotrophiclateralsclerosiswithoutdementiaaretrospectiveobservationalstudy AT fontanaandrea frontalassessmentbatteryfordetectingexecutivedysfunctioninamyotrophiclateralsclerosiswithoutdementiaaretrospectiveobservationalstudy AT panzafrancesco frontalassessmentbatteryfordetectingexecutivedysfunctioninamyotrophiclateralsclerosiswithoutdementiaaretrospectiveobservationalstudy AT copettimassimiliano frontalassessmentbatteryfordetectingexecutivedysfunctioninamyotrophiclateralsclerosiswithoutdementiaaretrospectiveobservationalstudy AT brunostefania frontalassessmentbatteryfordetectingexecutivedysfunctioninamyotrophiclateralsclerosiswithoutdementiaaretrospectiveobservationalstudy AT tursimarianna frontalassessmentbatteryfordetectingexecutivedysfunctioninamyotrophiclateralsclerosiswithoutdementiaaretrospectiveobservationalstudy AT iurilloannalisa frontalassessmentbatteryfordetectingexecutivedysfunctioninamyotrophiclateralsclerosiswithoutdementiaaretrospectiveobservationalstudy AT tortellirosanna frontalassessmentbatteryfordetectingexecutivedysfunctioninamyotrophiclateralsclerosiswithoutdementiaaretrospectiveobservationalstudy AT capozzorosa frontalassessmentbatteryfordetectingexecutivedysfunctioninamyotrophiclateralsclerosiswithoutdementiaaretrospectiveobservationalstudy AT simoneisabellalaura frontalassessmentbatteryfordetectingexecutivedysfunctioninamyotrophiclateralsclerosiswithoutdementiaaretrospectiveobservationalstudy AT logroscinogiancarlo frontalassessmentbatteryfordetectingexecutivedysfunctioninamyotrophiclateralsclerosiswithoutdementiaaretrospectiveobservationalstudy |